These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8009020)

  • 1. [Role of the titration of anti-neutrophil cytoplasmic antibodies in therapeutic follow-up of patients with systemic vasculitis].
    Bergelin A; Subra JF; Carrere F; Chevailler A; Masson C; Szapiro N; Riberi P
    Rev Med Interne; 1993; 14(10):1024. PubMed ID: 8009020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis.
    Gaskin G; Savage CO; Ryan JJ; Jones S; Rees AJ; Lockwood CM; Pusey CD
    Nephrol Dial Transplant; 1991; 6(10):689-94. PubMed ID: 1754104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis.
    De'Oliviera J; Gaskin G; Dash A; Rees AJ; Pusey CD
    Am J Kidney Dis; 1995 Mar; 25(3):380-9. PubMed ID: 7872315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sensitivity and specificity of antineutrophil cytoplasmic antibodies in systemic vasculitis].
    Hachulla E; Hatron PY; Brouillard M; Cesbron JY; Reumaux D; Devulder B
    Rev Med Interne; 1994 May; 15(6):381-6. PubMed ID: 7914710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble interleukin 2 receptor levels in anti-neutrophil cytoplasmic autoantibodies--positive systemic vasculitis.
    Lai KN; Lockwood CM
    Postgrad Med J; 1993 Sep; 69(815):708-11. PubMed ID: 8255836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neutrophil cytoplasmic antibodies: tools for diagnosis and follow-up in systemic vasculitis.
    Stegeman CA; Tervaert JW; Kallenberg CG
    Ann Med Interne (Paris); 1994; 145(8):523-32. PubMed ID: 7710178
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of the ANCA test for diagnosis of systemic necrotizing vasculitis.
    Andrassy K; Ritz E
    Contrib Nephrol; 1991; 94():22-30. PubMed ID: 1807893
    [No Abstract]   [Full Text] [Related]  

  • 8. Two sisters with ANCA positive vasculitis.
    Murphy EA; Sturrock RD; Fox JG; Boulton-Jones JM
    Ann Rheum Dis; 1993 May; 52(5):385. PubMed ID: 8323389
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-neutrophil cytoplasmic antibodies in vasculitis peripheral neuropathy.
    Chalk CH; Homburger HA; Dyck PJ
    Neurology; 1993 Sep; 43(9):1826-7. PubMed ID: 8414041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANCA and predicting relapse in systemic vasculitis.
    Jayne DR; Gaskin G; Pusey CD; Lockwood CM
    QJM; 1995 Feb; 88(2):127-33. PubMed ID: 7704563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis.
    Kyndt X; Reumaux D; Bridoux F; Tribout B; Bataille P; Hachulla E; Hatron PY; Duthilleul P; Vanhille P
    Am J Med; 1999 May; 106(5):527-33. PubMed ID: 10335724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of systemic vasculitis with pooled intravenous immunoglobulin.
    Jayne DR; Davies MJ; Fox CJ; Black CM; Lockwood CM
    Lancet; 1991 May; 337(8750):1137-9. PubMed ID: 1674023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-cytoplasm antibodies of neutrophil polynuclear antibodies and associated diseases].
    Chevailler A; Renier G; Subra JF
    Ann Med Interne (Paris); 1991; 142(7):530-42. PubMed ID: 1686380
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating intercellular adhesion molecules-1 and autoantibodies including anti-endothelial cell, anti-cardiolipin, and anti-neutrophil cytoplasma antibodies in patients with vasculitis.
    Wang CR; Liu MF; Tsai RT; Chuang CY; Chen CY
    Clin Rheumatol; 1993 Sep; 12(3):375-80. PubMed ID: 8258240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
    Tervaert JW; Limburg PC; Elema JD; Huitema MG; Horst G; The TH; Kallenberg CG
    Am J Med; 1991 Jul; 91(1):59-66. PubMed ID: 1677531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANCA-associated renal disease.
    Gaskin G; Pusey CD
    Q J Med; 1993 Feb; 86(2):138-9. PubMed ID: 8464993
    [No Abstract]   [Full Text] [Related]  

  • 17. IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis.
    Jayne DR; Weetman AP; Lockwood CM
    Clin Exp Immunol; 1991 Jun; 84(3):476-81. PubMed ID: 2044229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
    Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
    Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antineutrophil cytoplasmic antibodies as marker and follow-up parameter of vasculitis and glomerulonephritis].
    Wüthrich RP
    Praxis (Bern 1994); 1994 Oct; 83(43):1202-6. PubMed ID: 7973270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis.
    Nowack R; Grab I; Flores-Suarèz LF; Schnülle P; Yard B; van der Woude FJ
    Nephrol Dial Transplant; 2001 Aug; 16(8):1631-7. PubMed ID: 11477166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.